Biogen Pharmachem
0.49
-0.01(-2.00%)
Market Cap₹44.20 Cr
PE Ratio16.67
Company Performance:
1D-2.00%
1M-7.55%
6M-41.67%
1Y-47.87%
5Y+104.17%
View Company Insightsright
More news about Biogen Pharmachem
05Jan 26
Biogen Pharmachem Industries Submits Q3FY26 SEBI Compliance Certificate
Biogen Pharmachem Industries Limited submitted its Q3FY26 compliance certificate under SEBI Regulation 74(5) on January 5, 2026, covering the quarter ended December 31, 2025. The certificate, issued by registrar Satellite Corporate Services Private Limited, confirms no physical share certificates were received for dematerialization during the quarter, maintaining regulatory transparency for the BSE-listed pharmaceutical company.
 no imag found
23Jul 25
Biogen Pharmachem Industries Reports Impressive Turnaround with Rs 134.48 Lakh Net Profit in Q1
Biogen Pharmachem Industries Limited has reported a significant financial turnaround in Q1. The company's net profit rose to Rs 134.48 lakhs, compared to a loss of Rs 15.83 lakhs in the same quarter last year. Revenue from operations increased to Rs 154.28 lakhs from a negative Rs 9.09 lakhs. Total expenses increased to Rs 19.80 lakhs. The company's paid-up equity share capital rose to Rs 9,026.03 lakhs. Auditors found no issues with the financial results.
 no imag found
Biogen Pharmachem
0.49
-0.01
(-2.00%)
1 Year Returns:-47.87%
Industry Peers
LKP Finance
207.20
(-0.26%)
Algoquant Fintech
54.55
(-0.82%)
Kalind
100.49
(+0.96%)
Prime Securities
282.95
(-1.08%)
RNFI Services
279.00
(-0.87%)
NDL Ventures
118.85
(-0.26%)
Stellant Securities
642.65
(+5.00%)